Jaji, Noraida J.
HRN: 10-35-53 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/01/2024
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
07/01/2024
07/07/2024
IVTT
250mg
Q8h
T/c Acute Appendicitis
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes